Skip to main content
Top
Published in: Neurotherapeutics 2/2013

01-04-2013 | Review

Neuromuscular and Systemic Presentations in Adults: diagnoses beyond MERRF and MELAS

Author: Bruce H. Cohen

Published in: Neurotherapeutics | Issue 2/2013

Login to get access

Abstract

Mitochondrial diseases are a diverse group of inherited and acquired disorders that result in inadequate energy production. They can be caused by inheritable genetic mutations, acquired somatic mutations, and exposure to toxins (including some prescription medications). Normal mitochondrial physiology is responsible, in part, for the aging process itself, as free radical production within the mitochondria results in a lifetime burden of oxidative damage to DNA, especially the mitochondrial DNA that, in turn, replicate the mutational burden in future copies of itself, and lipid membranes. Primary mitochondrial diseases are those caused by mutations in genes that encode for mitochondrial structural and enzymatic proteins, and those proteins required for mitochondrial assembly and maintenance. A number of common adult maladies are associated with defective mitochondrial energy production and function, including diabetes, obesity, hyperthyroidism, hypothyroidism, and hyperlipidemia. Mitochondrial dysfunction has been demonstrated in many neurodegenerative disorders, including Alzheimer’s disease, Parkinson disease, amyotrophic lateral sclerosis, and some cancers. Polymorphisms in mitochondrial DNA have been linked to disease susceptibility, including death from sepsis and survival after head injury. There is considerable overlap in symptoms caused by primary mitochondrial diseases and those illnesses that affect mitochondrial function, but are not caused by primary mutations, as well as disorders that mimic mitochondrial diseases, but are caused by other identified mutations. Evaluation of these disorders is complex, expensive, and not without false-negative and false-positive results that can mislead the physician. Most of the common heritable mitochondrial disorders have been well-described in the literature, but can be overlooked by many clinicians if they are uneducated about these disorders. In general, the evaluation of the classic mitochondrial disorders has become straightforward if the clinician recognized the phenotype and orders appropriate confirmatory testing. However, the majority of patients referred for a mitochondrial evaluation do not have a clear presentation that allows for rapid identification and testing. This article provides introductory comments on mitochondrial structure, physiology, and genetics, but will focus on the presentation and evaluation of adults with mitochondrial symptoms, but who may not have a primary mitochondrial disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference DiMauro S, Bonilla E. Mitochondrial encephalomyopathies. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL (eds) The molecular and genetic basis of neurological disease. Butterworth-Heinemann, Boston, MA; 1997: pp. 201–235 DiMauro S, Bonilla E. Mitochondrial encephalomyopathies. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL (eds) The molecular and genetic basis of neurological disease. Butterworth-Heinemann, Boston, MA; 1997: pp. 201–235
2.
go back to reference Shoffner JM, Wallace DC. Oxidative phosphorylation diseases. In: Scriver CR, Beaudet AL, Sly WS, et al. (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York; 1995: pp. 1535–1610. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases. In: Scriver CR, Beaudet AL, Sly WS, et al. (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York; 1995: pp. 1535–1610.
3.
go back to reference DiMauro S, Schon EA,.The mitochondrial respiratory chain and its disorders. In: DiMauro S, Hirano M, Schon EA (eds) Mitochondrial medicine. Informa Healthcare, Boca Raton, FL; 2006: pp. 7–26 DiMauro S, Schon EA,.The mitochondrial respiratory chain and its disorders. In: DiMauro S, Hirano M, Schon EA (eds) Mitochondrial medicine. Informa Healthcare, Boca Raton, FL; 2006: pp. 7–26
4.
go back to reference Wallace DC, Fan W, Procaccio V. Mitochondrial energetics and therapeutics. Annu Rev Pathol 2010;5:297–348.PubMedCrossRef Wallace DC, Fan W, Procaccio V. Mitochondrial energetics and therapeutics. Annu Rev Pathol 2010;5:297–348.PubMedCrossRef
5.
go back to reference Cooper JM, Clark JB. The structural organization of the mitochondrial respiratory chain. In: Schapira AHV, DiMauro S (eds) Mitochondrial disorders in neurology. Butterworth-Heinemann, Oxford; 1994; pp. 1–30. Cooper JM, Clark JB. The structural organization of the mitochondrial respiratory chain. In: Schapira AHV, DiMauro S (eds) Mitochondrial disorders in neurology. Butterworth-Heinemann, Oxford; 1994; pp. 1–30.
6.
go back to reference Pagliarini DJ, Calvo SE, Chang B, et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008;134:112–123.PubMedCrossRef Pagliarini DJ, Calvo SE, Chang B, et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008;134:112–123.PubMedCrossRef
7.
go back to reference Haas RH, Parikh S, Falk MH, et al. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 2008;94:16–37.PubMedCrossRef Haas RH, Parikh S, Falk MH, et al. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 2008;94:16–37.PubMedCrossRef
8.
go back to reference Bernier FP, Boneh A, Dennett X, et al. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 2002;59:1406–1411.PubMedCrossRef Bernier FP, Boneh A, Dennett X, et al. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 2002;59:1406–1411.PubMedCrossRef
9.
go back to reference Wolf NI, Smeitink JA. Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children. Neurology 2002;59:1402–1405.PubMedCrossRef Wolf NI, Smeitink JA. Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children. Neurology 2002;59:1402–1405.PubMedCrossRef
10.
go back to reference Friedman SD, Shaw DW, Ishak G, Gropman AL, Saneto RP. The use of neuroimaging in the diagnosis of mitochondrial disease. Dev Disabil Res Rev 2010;16:129–135. Friedman SD, Shaw DW, Ishak G, Gropman AL, Saneto RP. The use of neuroimaging in the diagnosis of mitochondrial disease. Dev Disabil Res Rev 2010;16:129–135.
11.
go back to reference Hammans SR, Morgan-Hughes JA. Mitochondrial myopathies: clinical features, investigation, treatment and genetic counseling. In: Schapira AHV, DiMauro S (eds) Mitochondrial disorders in neurology. Butterworth-Heinemann, Oxford; 1994: pp. 1–30. Hammans SR, Morgan-Hughes JA. Mitochondrial myopathies: clinical features, investigation, treatment and genetic counseling. In: Schapira AHV, DiMauro S (eds) Mitochondrial disorders in neurology. Butterworth-Heinemann, Oxford; 1994: pp. 1–30.
12.
13.
go back to reference Hinson JT, Fantin VR, Schönberger J, et al. Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome. N Engl J Med 2007;356:809–819.PubMedCrossRef Hinson JT, Fantin VR, Schönberger J, et al. Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome. N Engl J Med 2007;356:809–819.PubMedCrossRef
14.
go back to reference Schon EA. Mitochondrial DNA and the genetics of mitochondrial disease. In: Schapira AHV, DiMauro S (eds) Mitochondrial disorders in neurology. Butterworth-Heinemann, Oxford; 1994; pp. 31–48. Schon EA. Mitochondrial DNA and the genetics of mitochondrial disease. In: Schapira AHV, DiMauro S (eds) Mitochondrial disorders in neurology. Butterworth-Heinemann, Oxford; 1994; pp. 31–48.
15.
go back to reference Fan W, Waymire KG, Narula N, et al. A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations. Science 2008;319:958–962.PubMedCrossRef Fan W, Waymire KG, Narula N, et al. A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations. Science 2008;319:958–962.PubMedCrossRef
16.
go back to reference Stewart JD, Horvath R, Baruffini E, et al. Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicity. Hepatology 2010;52:1791–1796.PubMedCrossRef Stewart JD, Horvath R, Baruffini E, et al. Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicity. Hepatology 2010;52:1791–1796.PubMedCrossRef
17.
go back to reference Wallace DC. Mitochondrial DNA mutations and bioenergetic defects in aging and degenerative diseases. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL (eds). The molecular and genetic basis of neurologic disease. Butterworth-Heinemann, Boston, MA; 1997: pp. 237–269 Wallace DC. Mitochondrial DNA mutations and bioenergetic defects in aging and degenerative diseases. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL (eds). The molecular and genetic basis of neurologic disease. Butterworth-Heinemann, Boston, MA; 1997: pp. 237–269
18.
go back to reference Melov S, Shoffner JM, Kaufman A, Wallace DC. Marked increase in the number and variety of mitochondrial DNA rearrangements in aging human skeletal muscle. Nucleic Acids Res 1995;23:4122–4126.PubMedCrossRef Melov S, Shoffner JM, Kaufman A, Wallace DC. Marked increase in the number and variety of mitochondrial DNA rearrangements in aging human skeletal muscle. Nucleic Acids Res 1995;23:4122–4126.PubMedCrossRef
19.
go back to reference Andreu AL, Hanna MG, Reichmann H, et al. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med 1999;341:1037–1044.PubMedCrossRef Andreu AL, Hanna MG, Reichmann H, et al. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med 1999;341:1037–1044.PubMedCrossRef
20.
go back to reference Prezant TR, Agapian JV, Bohlman MC, et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 1993;4:289–294.PubMedCrossRef Prezant TR, Agapian JV, Bohlman MC, et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 1993;4:289–294.PubMedCrossRef
21.
go back to reference Corral-Debrinski M, Shoffner JM, Lott MT, Wallace DC. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat Res 1992;275:169–180.PubMedCrossRef Corral-Debrinski M, Shoffner JM, Lott MT, Wallace DC. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat Res 1992;275:169–180.PubMedCrossRef
24.
go back to reference Gerrits KH, Voermans NC, de Haan A, van Engelen BG. Neuromuscular properties of the thigh muscles in patients with Ehlers-Danlos syndrome. Muscle Nerve 2013;47:96–104.PubMedCrossRef Gerrits KH, Voermans NC, de Haan A, van Engelen BG. Neuromuscular properties of the thigh muscles in patients with Ehlers-Danlos syndrome. Muscle Nerve 2013;47:96–104.PubMedCrossRef
25.
go back to reference Celletti C, Galli M, Cimolin V, Castori M, Albertini G, Camerota F. Relationship between fatigue and gait abnormality in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type. Res Dev Disabil 2012;33:1914–1918.PubMedCrossRef Celletti C, Galli M, Cimolin V, Castori M, Albertini G, Camerota F. Relationship between fatigue and gait abnormality in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type. Res Dev Disabil 2012;33:1914–1918.PubMedCrossRef
26.
go back to reference Voermans NC, van Alfen N, Pillen S, Lammens M, Schalkwijk J, Zwarts MJ, et al. Neuromuscular involvement in various types of Ehlers-Danlos syndrome. Ann Neurol 2009;65:687–697.PubMedCrossRef Voermans NC, van Alfen N, Pillen S, Lammens M, Schalkwijk J, Zwarts MJ, et al. Neuromuscular involvement in various types of Ehlers-Danlos syndrome. Ann Neurol 2009;65:687–697.PubMedCrossRef
28.
go back to reference Barbeau A. The syndrome of hereditary late-onset ptosis and dysphagia in French Canada. In: Kuhn E (ed.) Symposium über progressive muskeldystrophie. Springer-Verlag, Berlin; 1996: pp. 102–109. Barbeau A. The syndrome of hereditary late-onset ptosis and dysphagia in French Canada. In: Kuhn E (ed.) Symposium über progressive muskeldystrophie. Springer-Verlag, Berlin; 1996: pp. 102–109.
29.
go back to reference Quinlivan R, Jungbluth H. Myopathic causes of exercise intolerance with rhabdomyolysis. Dev Med Child Neurol 2012;54:886–891.PubMedCrossRef Quinlivan R, Jungbluth H. Myopathic causes of exercise intolerance with rhabdomyolysis. Dev Med Child Neurol 2012;54:886–891.PubMedCrossRef
30.
go back to reference Michot C, Hubert L, Romero NB, et al. Study of LPIN1, LPIN2 and LPIN3 in rhabdomyolysis and exercise-induced myalgia. J Inherit Metab Dis 2012;35:1119–1128.PubMedCrossRef Michot C, Hubert L, Romero NB, et al. Study of LPIN1, LPIN2 and LPIN3 in rhabdomyolysis and exercise-induced myalgia. J Inherit Metab Dis 2012;35:1119–1128.PubMedCrossRef
31.
go back to reference Pavlakis SG, Phillips PC, DiMauro S, DeVivo DC, Rowland LP. Mitochondrial myopathy, encephalomyopathy, lactic acidosis and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984;16:481–488.PubMedCrossRef Pavlakis SG, Phillips PC, DiMauro S, DeVivo DC, Rowland LP. Mitochondrial myopathy, encephalomyopathy, lactic acidosis and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984;16:481–488.PubMedCrossRef
32.
go back to reference Goto Y, Nonaka I, Horai S. A mutation in the tRNALeu(URR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:653.CrossRef Goto Y, Nonaka I, Horai S. A mutation in the tRNALeu(URR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:653.CrossRef
33.
go back to reference Bardosi A, Creutzfeldt W, DiMauro S, et al. Myo-, neuro-, gastrointestinal encephalomyopathy (MNGIE syndrome) due to partial deficiency of cytochrome c oxidase: a new mitochondrial multisystem disorder. Acta Neuropathol (Berl) 1987;74:(3)248–258. Bardosi A, Creutzfeldt W, DiMauro S, et al. Myo-, neuro-, gastrointestinal encephalomyopathy (MNGIE syndrome) due to partial deficiency of cytochrome c oxidase: a new mitochondrial multisystem disorder. Acta Neuropathol (Berl) 1987;74:(3)248–258.
34.
go back to reference Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999;283:689–692.PubMedCrossRef Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999;283:689–692.PubMedCrossRef
35.
go back to reference Zhang F, Wang S, Gan L, Vosler PS, Gao Y, Zigmond MJ, Chen J. Protective effects and mechanisms of sirtuins in the nervous system. Prog Neurobiol 2011;95:373–395.PubMedCrossRef Zhang F, Wang S, Gan L, Vosler PS, Gao Y, Zigmond MJ, Chen J. Protective effects and mechanisms of sirtuins in the nervous system. Prog Neurobiol 2011;95:373–395.PubMedCrossRef
36.
go back to reference Ventura-Clapier R, Garnier A, Veksler V. Energy metabolism in heart failure. J Physiol 2004;555:1–13.PubMedCrossRef Ventura-Clapier R, Garnier A, Veksler V. Energy metabolism in heart failure. J Physiol 2004;555:1–13.PubMedCrossRef
37.
go back to reference Lietman PS. Mitochondrial protein synthesis: inhibition by emetine hydrochloride. Mol Pharmacol 1971;7:122–128.PubMed Lietman PS. Mitochondrial protein synthesis: inhibition by emetine hydrochloride. Mol Pharmacol 1971;7:122–128.PubMed
38.
go back to reference Hirano M, Kaufmann P, De Vivo D, Tanji K. Mitochondrial neurology I: encephlopathies. In: DiMauro S, Hirano M, Schon EA (eds) Mitochondrial medicine. Informa Healthcare, Boca Raton, FL; 2006: pp. 27–44 Hirano M, Kaufmann P, De Vivo D, Tanji K. Mitochondrial neurology I: encephlopathies. In: DiMauro S, Hirano M, Schon EA (eds) Mitochondrial medicine. Informa Healthcare, Boca Raton, FL; 2006: pp. 27–44
39.
go back to reference Goodfellow JA, Dani K, Stewart W, Santosh C, McLean J, Mulhern S, Razvi S. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: an important cause of stroke in young people. Postgrad Med J 2012;88:326–334.PubMedCrossRef Goodfellow JA, Dani K, Stewart W, Santosh C, McLean J, Mulhern S, Razvi S. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: an important cause of stroke in young people. Postgrad Med J 2012;88:326–334.PubMedCrossRef
40.
go back to reference Jobgen WS, Fried SK, Fu WJ, Meininger CJ, Wu G. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem 2006;17:571–588.PubMedCrossRef Jobgen WS, Fried SK, Fu WJ, Meininger CJ, Wu G. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem 2006;17:571–588.PubMedCrossRef
41.
42.
43.
go back to reference Cohen BH, Naviaux RK. The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders. Methods 2010;51:364–373.PubMedCrossRef Cohen BH, Naviaux RK. The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders. Methods 2010;51:364–373.PubMedCrossRef
45.
go back to reference Saneto RP, Lee I-C, Koenig MK, Bao X, Weng SW, Naviaux RK, Wong L-J. POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders. Seizure 2010;19:140–146.PubMedCrossRef Saneto RP, Lee I-C, Koenig MK, Bao X, Weng SW, Naviaux RK, Wong L-J. POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders. Seizure 2010;19:140–146.PubMedCrossRef
46.
go back to reference Huang CC, Chu CC, Pang CY, Wei YH. Tissue mosaicism in the skeletal muscle and sural nerve biopsies in the MELAS syndrome. Acta Neurol Scand 1999; 99:125–129.PubMedCrossRef Huang CC, Chu CC, Pang CY, Wei YH. Tissue mosaicism in the skeletal muscle and sural nerve biopsies in the MELAS syndrome. Acta Neurol Scand 1999; 99:125–129.PubMedCrossRef
47.
go back to reference Peyronnard JM, Charron L, Bellavance A, Marchand L. Neuropathy and mitochondrial myopathy. Ann Neurol 1980;7:262–268.PubMedCrossRef Peyronnard JM, Charron L, Bellavance A, Marchand L. Neuropathy and mitochondrial myopathy. Ann Neurol 1980;7:262–268.PubMedCrossRef
48.
go back to reference Wenning GK, Stefanova N. Recent developments in multiple system atrophy. J Neurol 2009;256:1791–808.PubMedCrossRef Wenning GK, Stefanova N. Recent developments in multiple system atrophy. J Neurol 2009;256:1791–808.PubMedCrossRef
50.
go back to reference Kenny D, Wetherbee J. Kearns-Sayre syndrome in the elderly: mitochondrial myopathy with advanced heart block. Am Heart J 1990;120:440–443.PubMedCrossRef Kenny D, Wetherbee J. Kearns-Sayre syndrome in the elderly: mitochondrial myopathy with advanced heart block. Am Heart J 1990;120:440–443.PubMedCrossRef
51.
go back to reference Mashima Y, Kigasawa K, Hasegawa H, Tani M, Oguchi Y. High incidence of pre-excitation syndrome in Japanese families with Leber’s hereditary optic neuropathy. Clin Genet 1996; 50:535–537.PubMedCrossRef Mashima Y, Kigasawa K, Hasegawa H, Tani M, Oguchi Y. High incidence of pre-excitation syndrome in Japanese families with Leber’s hereditary optic neuropathy. Clin Genet 1996; 50:535–537.PubMedCrossRef
52.
go back to reference Vydt TC, de Coo RF, Soliman OI, et al. Cardiac involvement in adults with m.3243A > G MELAS gene mutation. Am J Cardiol 2007;99:264–269.PubMedCrossRef Vydt TC, de Coo RF, Soliman OI, et al. Cardiac involvement in adults with m.3243A > G MELAS gene mutation. Am J Cardiol 2007;99:264–269.PubMedCrossRef
53.
54.
go back to reference Bindoff L. Mitochondrial gastroenterology. In: DiMauro S, Hirano M, Schon EA (eds) Mitochondrial medicine. Informa Healthcare, Boca Raton, FL; 2006: pp. 143–159 Bindoff L. Mitochondrial gastroenterology. In: DiMauro S, Hirano M, Schon EA (eds) Mitochondrial medicine. Informa Healthcare, Boca Raton, FL; 2006: pp. 143–159
55.
go back to reference Vial G, Dubouchaud H, Leverve XM. Liver mitochondria and insulin resistance. Acta Biochim Pol 2010;57:389–392.PubMed Vial G, Dubouchaud H, Leverve XM. Liver mitochondria and insulin resistance. Acta Biochim Pol 2010;57:389–392.PubMed
56.
go back to reference Serviddio G, Bellanti F, Vendemiale G, Altomare E. Mitochondrial dysfunction in nonalcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol 2011;5:233–244.PubMedCrossRef Serviddio G, Bellanti F, Vendemiale G, Altomare E. Mitochondrial dysfunction in nonalcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol 2011;5:233–244.PubMedCrossRef
57.
go back to reference Wong L-J C, Naviaux RK, Brunetti-Pierri, N, et al. Molecular and clinical genetics of mitochondrial diseases due to POLG Mutations. Hum Mutat 2008;29:E150-172.PubMedCrossRef Wong L-J C, Naviaux RK, Brunetti-Pierri, N, et al. Molecular and clinical genetics of mitochondrial diseases due to POLG Mutations. Hum Mutat 2008;29:E150-172.PubMedCrossRef
58.
59.
go back to reference Fraser JA, Biousse V, Newman NJ. The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol 2010;55:299–334.PubMedCrossRef Fraser JA, Biousse V, Newman NJ. The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol 2010;55:299–334.PubMedCrossRef
60.
go back to reference Kerrison JB, Biousse V, Newman NJ. Retinopathy of NARP syndrome. Arch Ophthalmol 2000;118:298–299.PubMedCrossRef Kerrison JB, Biousse V, Newman NJ. Retinopathy of NARP syndrome. Arch Ophthalmol 2000;118:298–299.PubMedCrossRef
61.
go back to reference Smith PR, Bain SC, Good PA, et al. Pigmentary retinal dystrophy and the syndrome of maternally inherited diabetes and deafness cause by the mitochondrial DNA 3243 tRNA (Leu) A to G mutation. Ophthalmology 1999;106:1101–1108.PubMedCrossRef Smith PR, Bain SC, Good PA, et al. Pigmentary retinal dystrophy and the syndrome of maternally inherited diabetes and deafness cause by the mitochondrial DNA 3243 tRNA (Leu) A to G mutation. Ophthalmology 1999;106:1101–1108.PubMedCrossRef
62.
go back to reference Sitarz KS, Chinnery PF, Yu-Wai-Man P. Disorders of the optic nerve in mitochondrial cytopathies: new ideas on pathogenesis and therapeutic targets. Curr Neurol Neurosci Rep 2012;12:308–317.PubMedCrossRef Sitarz KS, Chinnery PF, Yu-Wai-Man P. Disorders of the optic nerve in mitochondrial cytopathies: new ideas on pathogenesis and therapeutic targets. Curr Neurol Neurosci Rep 2012;12:308–317.PubMedCrossRef
63.
go back to reference Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 1988;242:1427–1430.PubMedCrossRef Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 1988;242:1427–1430.PubMedCrossRef
64.
go back to reference Chalmers RM, Schapira AH. Clinical, biochemical and molecular genetic features of Leber’s hereditary optic neuropathy. Biochim Biophys Acta 1999;1410:147–158.PubMedCrossRef Chalmers RM, Schapira AH. Clinical, biochemical and molecular genetic features of Leber’s hereditary optic neuropathy. Biochim Biophys Acta 1999;1410:147–158.PubMedCrossRef
65.
go back to reference Zeviani M. OPA1 mutations and mitochondrial DNA damage: keeping the magic circle in shape. Brain 2008;131:314–317.PubMedCrossRef Zeviani M. OPA1 mutations and mitochondrial DNA damage: keeping the magic circle in shape. Brain 2008;131:314–317.PubMedCrossRef
66.
go back to reference Leonard JV, Schapira AH. Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet 2000;335:299–304CrossRef Leonard JV, Schapira AH. Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet 2000;335:299–304CrossRef
67.
go back to reference McFarland R, Taylor RW, Chinnery PF et al. A novel sporadic mutation in cytochrome c oxidase subunit II as a cause of rhabdomyolysis. Neuromuscul Disord 2004;14:162–166.PubMedCrossRef McFarland R, Taylor RW, Chinnery PF et al. A novel sporadic mutation in cytochrome c oxidase subunit II as a cause of rhabdomyolysis. Neuromuscul Disord 2004;14:162–166.PubMedCrossRef
68.
go back to reference Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 2008;83:254–260.PubMedCrossRef Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 2008;83:254–260.PubMedCrossRef
69.
go back to reference Fischel-Ghodsian N. Mitochondrial genetics and hearing loss: the missing link between genotype and phenotype. Proc Soc Exp Biol Med 1998;218:1–6.PubMed Fischel-Ghodsian N. Mitochondrial genetics and hearing loss: the missing link between genotype and phenotype. Proc Soc Exp Biol Med 1998;218:1–6.PubMed
71.
go back to reference Ballana E, Morales E, Rabionet R, et al. Mitochondrial 12S rRNA gene mutations affect RNA secondary structure and lead to variable penetrance in hearing impairment. Biochem Biophys Res Commun 2006;341:950–957.PubMedCrossRef Ballana E, Morales E, Rabionet R, et al. Mitochondrial 12S rRNA gene mutations affect RNA secondary structure and lead to variable penetrance in hearing impairment. Biochem Biophys Res Commun 2006;341:950–957.PubMedCrossRef
72.
go back to reference Guan MX, Yan Q, Li X, et al. Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations. Am J Hum Genet 2006;79:291–302.PubMedCrossRef Guan MX, Yan Q, Li X, et al. Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations. Am J Hum Genet 2006;79:291–302.PubMedCrossRef
74.
75.
go back to reference Guéry B, Choukroun G, Noël LH, et al. The spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA(Leu) gene mutation. J Am Soc Nephrol 2003;14:2099–2108.PubMedCrossRef Guéry B, Choukroun G, Noël LH, et al. The spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA(Leu) gene mutation. J Am Soc Nephrol 2003;14:2099–2108.PubMedCrossRef
76.
go back to reference Doleris LM, Hill GS, Chedin P, et al. Focal segmental glomerulosclerosis associated with mitochondrial cytopathy. Kidney Int 2000;58:1851–1858.PubMedCrossRef Doleris LM, Hill GS, Chedin P, et al. Focal segmental glomerulosclerosis associated with mitochondrial cytopathy. Kidney Int 2000;58:1851–1858.PubMedCrossRef
77.
go back to reference Luft R, Ikkos D, Palmieri G, Ernster L, Afzelius B. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest 1962;41:1776–1804.PubMedCrossRef Luft R, Ikkos D, Palmieri G, Ernster L, Afzelius B. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest 1962;41:1776–1804.PubMedCrossRef
78.
go back to reference Odawara M. Involvement of mitochondrial gene abnormalities in the pathogenesis of diabetes mellitus. Ann NY Acad Sci 1996; 786:72–81.PubMedCrossRef Odawara M. Involvement of mitochondrial gene abnormalities in the pathogenesis of diabetes mellitus. Ann NY Acad Sci 1996; 786:72–81.PubMedCrossRef
79.
go back to reference Gerbitz KD, van den Ouweland JM, Maassen JA, Jaksch M. Mitochondrial diabetes mellitus: a review. Biochim Biophys Acta 1995;1271:253–260.PubMedCrossRef Gerbitz KD, van den Ouweland JM, Maassen JA, Jaksch M. Mitochondrial diabetes mellitus: a review. Biochim Biophys Acta 1995;1271:253–260.PubMedCrossRef
80.
go back to reference van den Ouweland JM, Lemkes HH, et al. Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNA (Leu(URR)) gene. Diabetes 1994;43:746–751.PubMedCrossRef van den Ouweland JM, Lemkes HH, et al. Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNA (Leu(URR)) gene. Diabetes 1994;43:746–751.PubMedCrossRef
81.
go back to reference Anon. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 34–1987. A 30-year-old woman with an ocular motility disturbance, myopathy, and hypocalcemia. N Engl J Med 1987;317:493–501CrossRef Anon. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 34–1987. A 30-year-old woman with an ocular motility disturbance, myopathy, and hypocalcemia. N Engl J Med 1987;317:493–501CrossRef
82.
go back to reference Yang CY, Lam HC, Lee HC, et al. MELAS syndrome associated with diabetes mellitus and hyperthyroidism: a case report from Taiwan. Clin Endocrinol 1995;43:235–239.CrossRef Yang CY, Lam HC, Lee HC, et al. MELAS syndrome associated with diabetes mellitus and hyperthyroidism: a case report from Taiwan. Clin Endocrinol 1995;43:235–239.CrossRef
83.
go back to reference Finsterer J, Jarius C, Eichberger H. Phenotype variability in 130 adult patients with respiratory chain disorders. J Inherit Metab Dis 2001;24:560–576PubMedCrossRef Finsterer J, Jarius C, Eichberger H. Phenotype variability in 130 adult patients with respiratory chain disorders. J Inherit Metab Dis 2001;24:560–576PubMedCrossRef
84.
go back to reference Quade A, Zierz S, Klingmüller D. Endocrine abnormalities in mitochondrial myopathy with external ophthalmoplegia. Clin Invest 1992;70:396–402. Quade A, Zierz S, Klingmüller D. Endocrine abnormalities in mitochondrial myopathy with external ophthalmoplegia. Clin Invest 1992;70:396–402.
85.
go back to reference Chen CM, Huang CC. Gonadal dysfunction in mitochondrial encephalomyopathies. Eur Neurol 1995;35:281–286.PubMedCrossRef Chen CM, Huang CC. Gonadal dysfunction in mitochondrial encephalomyopathies. Eur Neurol 1995;35:281–286.PubMedCrossRef
86.
go back to reference Harvey JN, Barnett D. Endocrine dysfunction in Kearns-Sayre syndrome. Clin Endocrinol 1992;37:97–103.CrossRef Harvey JN, Barnett D. Endocrine dysfunction in Kearns-Sayre syndrome. Clin Endocrinol 1992;37:97–103.CrossRef
87.
go back to reference Matsuzaki M, Izumi T, Shishikura K, Suzuki H, Hirayama Y. Hypothalamic growth hormone deficiency and supplementary GH therapy in two patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. Neuropediatrics 2002;33:271–273.PubMedCrossRef Matsuzaki M, Izumi T, Shishikura K, Suzuki H, Hirayama Y. Hypothalamic growth hormone deficiency and supplementary GH therapy in two patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. Neuropediatrics 2002;33:271–273.PubMedCrossRef
88.
go back to reference Plioplys AV, Plioplys S. Serum levels of carnitine in chronic fatigue syndrome: clinical correlates. Neuropsychobiology 1995;32:132–138.PubMedCrossRef Plioplys AV, Plioplys S. Serum levels of carnitine in chronic fatigue syndrome: clinical correlates. Neuropsychobiology 1995;32:132–138.PubMedCrossRef
89.
go back to reference Kuratsune H, Yamaguti K, Takahashi M, Tagawa S, Kitani T. Acylcarnitine deficiency in chronic fatigue syndrome. Clin Infect Dis 1994;18(Suppl. 1):62–67.CrossRef Kuratsune H, Yamaguti K, Takahashi M, Tagawa S, Kitani T. Acylcarnitine deficiency in chronic fatigue syndrome. Clin Infect Dis 1994;18(Suppl. 1):62–67.CrossRef
90.
go back to reference Griggs RC, Karpati G. Muscle pain, fatigue, and mitochondriopathies. N Engl J Med 1999;341:1077–1078.PubMedCrossRef Griggs RC, Karpati G. Muscle pain, fatigue, and mitochondriopathies. N Engl J Med 1999;341:1077–1078.PubMedCrossRef
91.
go back to reference Smits B, van den Heuvel L, Knoop H, Küsters B, Janssen A, Borm G, et al. Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome. Mitochondrion 2011;11:735–738.PubMedCrossRef Smits B, van den Heuvel L, Knoop H, Küsters B, Janssen A, Borm G, et al. Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome. Mitochondrion 2011;11:735–738.PubMedCrossRef
Metadata
Title
Neuromuscular and Systemic Presentations in Adults: diagnoses beyond MERRF and MELAS
Author
Bruce H. Cohen
Publication date
01-04-2013
Publisher
Springer-Verlag
Published in
Neurotherapeutics / Issue 2/2013
Print ISSN: 1933-7213
Electronic ISSN: 1878-7479
DOI
https://doi.org/10.1007/s13311-013-0188-3

Other articles of this Issue 2/2013

Neurotherapeutics 2/2013 Go to the issue